Dr. Mikael Dolsten Named to Agilent Board of Directors
https://www.agilent.com/about/newsroom/presrel/2021/23sep-gp21025.html
WEBSep 23, 2021 · Agilent Technologies, Inc. (NYSE: A) today announced that Dr. Mikael Dolsten, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer Inc. has been elected to Agilent’s board of directors, effective Sept. 21, 2021. Dr. Dolsten brings 30 years of pharma experience to the Agilent board.
DA: 90 PA: 75 MOZ Rank: 58